1. Home
  2. FINV vs CSTL Comparison

FINV vs CSTL Comparison

Compare FINV & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$5.02

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.41

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
CSTL
Founded
2007
2007
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FINV
CSTL
Price
$5.02
$39.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$11.55
$43.17
AVG Volume (30 Days)
1.0M
351.9K
Earning Date
11-19-2025
02-26-2026
Dividend Yield
5.59%
N/A
EPS Growth
27.76
N/A
EPS
1.50
N/A
Revenue
$1,969,555,571.00
$343,530,000.00
Revenue This Year
$6.02
$1.69
Revenue Next Year
N/A
N/A
P/E Ratio
$3.45
N/A
Revenue Growth
8.81
10.15
52 Week Low
$4.70
$14.59
52 Week High
$11.08
$42.18

Technical Indicators

Market Signals
Indicator
FINV
CSTL
Relative Strength Index (RSI) 39.45 53.75
Support Level $5.17 $37.29
Resistance Level $5.49 $41.35
Average True Range (ATR) 0.21 1.36
MACD 0.00 -0.26
Stochastic Oscillator 0.00 38.49

Price Performance

Historical Comparison
FINV
CSTL

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: